AJANTA PHARMA
Back to Cashflow Statement
|
AJANTA PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹47 Cr | ₹-201 Cr | ₹124 Cr | ₹28 Cr | ₹-24 Cr |
What is the latest Net Cash Inflow / Outflow ratio of AJANTA PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹47 Cr |
| Mar2024 | ₹-201 Cr |
| Mar2023 | ₹124 Cr |
| Mar2022 | ₹28 Cr |
| Mar2021 | ₹-24 Cr |
How is Net Cash Inflow / Outflow of AJANTA PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹47 Cr | Positive | |
| Mar2024 | ₹-201 Cr | Negative | |
| Mar2023 | ₹124 Cr | 345.56 | |
| Mar2022 | ₹28 Cr | Positive | |
| Mar2021 | ₹-24 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹36,959.8 Cr | 1.4% | 9% | 18.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,054.0 Cr | 0.9% | 6.2% | -1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,075.0 Cr | 2% | 4.8% | 4.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,904.0 Cr | 3.6% | 6% | 36.9% | Stock Analytics | |
| CIPLA | ₹107,358.0 Cr | -0.1% | -3% | -8.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,813.0 Cr | 1% | 10.8% | 4.7% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | 1.4% |
9% |
18.8% |
| SENSEX | -1.4% |
0.4% |
8.3% |
You may also like the below Video Courses